Simon Fraser University   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Burnaby Canada (1965)

Organization Overview

First Clinical Trial
2011
NCT01334333
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Simon Fraser University | Simon Fraser University and International Collaboration on Repair Discoveries (ICORD)

Active Ingredients

Drugs in Phase 4 Trials (4)

brexpiprazole (rexulti) (2 trials)

escitalopram (lexapro) (2 trials)

lidocaine (xylocaine) (1 trial)

tacrolimus (prograf) (1 trial)

Drugs in Phase 2 Trials (1)

nitroglycerin (transderm-nitro) (1 trial)

Drugs in Other Trials (1)

water (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 3)

Depressive Disorder (Phase 3)

Depressive Disorder, Major (Phase 3)

Kidney Diseases (Phase 4)

Spinal Cord Injuries (Phase 4)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 6